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Background: We evaluated the associations between 25-hydroxyvitamin D (25(OH)D) concentrations in serum and insulin re-
sistance in the healthy Korean population.
Methods: We conducted this cross-sectional analysis in 1,807 healthy Korean people (628 men and 1,179 women) aged 30 to 64 
years in the Cardiovascular and Metabolic Disease Etiologic Research Center study. All participants were assessed for 25(OH)D, 
fasting glucose, and insulin levels, and completed a health examination and lifestyle questionnaire according to standard proce-
dures. Insulin resistance was defined as the homeostasis model assessment insulin resistance higher than the 75 percentile.
Results: Compared to those in the highest tertile (≥14.3 ng/mL), the odds ratio (OR) for insulin resistance was 1.37 (95% confi-
dence interval [CI], 1.01 to 1.86) for the 1st tertile (<9.7 ng/mL) and 1.19 (95% CI, 0.08 to 1.62) for the 2nd tertile (9.7 to 14.3 ng/
mL) after adjusting for age, gender, waist circumference, alcohol consumption, smoking status, physical exercise, season, and co-
hort. After stratification of the subjects by adiposity, these associations remained only in non-obese subjects (lowest tertile vs. 
highest tertile, multivariable OR, 1.64; 95% CI, 1.05 to 2.56). 
Conclusion: Serum 25(OH)D has an independent inverse association with insulin resistance in the healthy, non-obese Korean 
population, even among people with vitamin D insufficiency.
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INTRODUCTION
Vitamin D is not only a regulator of calcium-phosphorus me-
tabolism, but it also influences the onset of diseases, including 
diabetes, cardiovascular disease, and cancer [1,2]. The associa-
tion between vitamin D and glucose metabolism is particular-
ly important. Some studies have reported that vitamin D in-
sufficiency is more common in people with diabetes risk than 
people without such risk [3-5]. Other studies have linked low-
er 25-hydroxyvitamin D (25(OH)D) concentrations, a gener-
ally accepted indicator of vitamin D status, with insulin resis-
tance and β-cell dysfunction in Western populations [4,6,7]. 
However, there are differences in vitamin D metabolism and 
nutritional status between ethnic groups [3,8-10]. Asian coun-
tries, including Korea, have a relatively high prevalence of vi-
tamin D insufficiency compared to other countries [11-13]. 
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However, few studies have examined the relationship between 
25(OH)D concentration and insulin resistance in a healthy 
Asian population. In addition, previous studies suggested that 
this association may differ by obesity status [14,15]. 
In this cross-sectional study, we investigated the associa-
tions between 25(OH)D levels in serum and insulin resistance 
(represented by the homeostasis model assessment insulin re-
sistance [HOMA-IR]) in the healthy Korean population.  
METHODS
Study design and participants
This study was performed as part of the Cardiovascular and 
Metabolic Disease Etiologic Research Center (CMERC) study, 
which was undertaken beginning in 2013 to evaluate tradi-
tional risk factors, explore new biomarkers, clarify etiology, 
and suggest prevention strategies for cardiovascular and met-
abolic diseases. 
The CMERC population is a multicenter prospective co-
hort, which consists of two community-based cohorts and 
one hospital-based cohort of people at high risk for cardiovas-
cular diseases. The community-based cohorts included resi-
dents of urban and rural areas. Community-based cohort 1 
was based in the Seoul, Goyang-si, Gimpo-si, and Ganghwa-
gun; community-based cohort 2 was based in the Suwon-si, 
Yongin-si, and Hwaseong-si. We excluded persons who had 
been diagnosed with a malignancy within 2 years, were cur-
rently being treated, or had a history of myocardial infarction, 
stroke, or heart failure. 
Anthropometric measurements and serum biochemistry 
profiles were made for 1,807 subjects, all of whom were includ-
ed in this study. The level of serum 25(OH)D was 12.5 ng/mL 
(interquartile range [IQR], 9.8 to 16.1) in men and 11.1 ng/mL 
(IQR, 8.3 to 16.0) in women. No statistical difference was pres-
ent (P=0.481), so we analyzed them together. The participants 
were divided into three categories based on 25(OH)D concen-
tration: tertile 1 (<9.7 ng/mL), tertile 2 (9.7 to 14.3 ng/mL), and 
tertile 3 (≥14.3 ng/mL). The prevalence of high insulin resis-
tance was compared among these three groups. In addition, 
participants were divided into normal and obese according to 
body mass index (BMI) and waist circumference. General 
obesity was defined as a BMI of 25 kg/m2 or greater [16]. Ab-
dominal obesity was defined as a waist circumference of 90 cm 
or greater for male and 85 cm or greater for female [17]. The 
odds ratios (ORs) of insulin resistance according to 25(OH)D 
concentration were also compared among the groups.
This study was approved by the Institutional Review Boards 
of Severance Hospital at Yonsei University College of Medi-
cine (IRB No. 4-2013-0661) and Ajou University Hospital 
(AJIRB-BMR-SUR-13-272), and informed consent was ob-
tained from each participant.
Measurements
Information on subjects, including demographics, physical 
activities, and lifestyles were collected by face-to-face inter-
views. Trained researchers gathered all information using 
standardized questionnaires and protocols. All measurements 
were taken at the health-screening centers in Seoul and Su-
won, South Korea.
Body weights and heights were measured using standard-
ized techniques and equipment with participants who were 
wearing light indoor clothing without shoes (cohort 1, DS-102 
Jenix, Seoul, Korea for height; BB-150 CAS, Seongnam, Korea 
for weight; cohort 2, BSM 330, Biospace, Seoul, Korea). BMI 
was calculated as weight divided by height squared (kg/m2). 
Waist circumference was measured over the midpoint between 
the lower border of the ribs and the iliac crest in a standing po-
sition using a plastic tapeline. Blood pressure was measured 
three times in the right arm using an electronic manometer 
(HEM-7080IC; Omron Healthcare Co. Ltd., Kyoto, Japan) af-
ter 5 minutes of rest in the sitting position, and the average of 
the final two measurements was used for the analysis. 
Blood samples were obtained after a fasting period of at least 
8 hours, and all laboratory tests were performed in a central 
laboratory (Seoul Clinical Laboratories, Seoul, Korea). Serum 
fasting glucose was measured using the colorimetric method 
using an autoanalyzer (ADVIA 1800 Auto Analyzer; Siemens 
Medical Solutions, Malvern, PA, USA). The insulin level in se-
rum was measured using a radioimmunoassay (SR 300; 
STRATEC, Birkenfeld, Germany) and serum 25(OH)D con-
centration was measured using chemiluminescence immuno-
assay (CLIA) method (Liaison; DiaSorin, Dietzenbach, Ger-
many). Insulin resistance was measured using the HOMA-IR: 
fasting insulin (μIU/mL)×fasting glucose (mg/dL)/405. In 
both men and women, high insulin resistance was defined as 
an HOMA-IR score higher than the 75th percentile [18].
Demographic characteristics including age, gender, smok-
ing status, amount of alcohol consumption, physical exercise, 
and season of sampling (May to October, November to April) 
were collected by trained interviewers. Smoking status was di-
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vided into three categories: never smokers (if the subjects had 
smoked <100 cigarettes), former smokers (≥100 cigarettes in 
one’s lifetime but not currently a smoker), and current smok-
ers (≥100 cigarettes and reported “currently smoking” in the 
questionnaire). Alcohol consumption (in g/day) was assessed 
by inquiring about the frequency and average amount drunk 
during the most recent year; this was calculated by multiply-
ing the daily intake of each alcoholic beverage by its ethanol 
content. Physical exercise was measured using the Interna-
tional Physical Activity Questionnaire (IPAQ) and classified 
into three categories based on standard scoring criteria (http://
www.ipaq.ki.se): low, moderate, and high. Season was defined 
using the date participants completed blood collection and 
was classified as follows: May to October, November to April.
Statistical analysis
Differences between continuous variables according to 25(OH)D 
concentration were evaluated by analysis of variance and Tukey 
post hoc analyses. Categorical variables were compared using 
chi-square tests. All data are presented as mean±standard de-
viation or medians with IQRs. Multivariable logistic regres-
sion was used to assess the independent association of 25(OH)
D concentrations and high insulin resistance. We used three 
models with progressive degrees of adjustment. Model 1 was 
the unadjusted analysis. Model 2 adjusted for age and gender. 
Model 3 additionally adjusted for waist circumference, alco-
hol consumption, smoking status, physical exercise, season, 
and cohort (cohort 1 or cohort 2). The results are expressed as 
ORs and 95% confidence intervals (CIs). Furthermore, strati-
fied analysis between the normal and obese groups was per-
formed. All analyses were performed using SAS version 9.2 
(SAS Institute, Cary, NC, USA). P values <0.05 were consid-
ered statistically significant.
RESULTS 
Participant characteristics 
This study comprised a total of 1,807 subjects with a mean age 
of 49.6±8.8 years. Among them, 1,179 (65.2%) were women, 
and 628 (34.8%) were men. The median concentration of 
25(OH)D was 11.7 ng/mL (IQR, 8.8 to 16.0) and HOMA-IR 
was 1.7 (IQR, 1.4 to 2.2).  
Table 1 indicates the characteristics of each group according 
to serum 25(OH)D. The BMI, waist circumference, fasting 
glucose, systolic blood pressure, and amount of alcohol con-
sumption did not differ significantly among groups (Table 1). 
However, the lowest tertile, with the lowest 25(OH)D levels 
(<9.7 ng/mL), represented a higher proportion of younger 
people and women, high fasting insulin level, and less fre-
quent physical exercise compared to the other tertiles. 
Associations between 25(OH)D concentration and insulin 
resistance
Insulin resistance was inversely associated with 25(OH)D 
concentrations (Table 2). Compared to those in the highest 
tertile, the ORs of those with high insulin resistance was 1.57 
(95% CI, 1.21 to 2.04) in the lowest tertile and 1.31 (95% CI, 
1.00 to 1.71) in the 2nd tertile (P for trend=0.001) in the un-
adjusted analysis (model 1). This pattern remained after ad-
justments. After adjusting for age, gender, waist circumfer-
ence, alcohol intake, smoking status, physical exercise, season, 
and cohort, model 3 indicated higher ORs for high insulin re-
sistance in the lowest tertile (OR, 1.37; 95% CI, 1.01 to 1.86) 
and middle tertile (OR, 1.19; 95% CI, 0.88 to 1.62) compared 
with the highest tertile (P for trend=0.042).
The results of the stratified analysis with general obesity by 
BMI and abdominal obesity by waist circumference are given in 
Table 3, Supplementary Table 1, Fig. 1. The results are based on 
the common reference group with serum 25(OH)D in the high-
est tertile and non-obese. Compared to the reference group, the 
risk of insulin resistance among subjects with general obesity 
(BMI ≥25 kg/m2) and serum 25(OH)D in the lowest tertile was 
1.95 times higher, and subjects with normal (BMI <25 kg/m2) 
and serum 5(OH)D in the lowest tertile had about a 1.41-fold 
increase risk of insulin resistance. However, there was no differ-
ence in the results according to abdominal obesity (Fig. 1). 
Table 3 shows the association between insulin resistance 
and 25(OH)D concentrations that remained in the non-gen-
eral obesity group; however, there was no significant associa-
tion in the general obesity group (lowest tertile vs. highest ter-
tile; normal obesity [OR, 1.64; 95% CI, 1.05 to 2.56]; general 
obesity [OR, 0.97; 95% CI, 0.63 to 1.48]). After stratification 
by abdominal obesity, there was no significant association for 
each of the groups (lowest tertile vs. highest tertile; normal 
obesity [OR, 1.33; 95% CI, 0.92 to 1.93]; abdominal obesity 
[OR, 1.38; 95% CI, 0.81 to 2.37]).  
DISCUSSION
We found that lower serum 25(OH)D concentrations are in-
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dependently associated with high insulin resistance even after 
adjustments. This inverse relationship is consistent with some 
previous epidemiologic studies [8-10]. A large cross-sectional 
study from the Third National Health and Nutrition Exami-
nation Survey revealed an inverse association between vita-
min D status and insulin resistance in non-Hispanic white 
people and Mexican-Americans [10]. Similarly, studies on 
Asian populations have indicated that low circulating 25(OH)
D levels are correlated with high fasting insulin levels and 
high HOMA-IR scores [8,9]. 
Table 1. Characteristics of study participants: the CMERC study
Characteristic
Serum 25(OH)D, ng/mL
P valuea
Tertile 3 (≥14.3) Tertile 2 (9.7–14.3) Tertile 1 (<9.7)
Number 611 595 601
Age, yr 51.0±8.3 48.7±9.1 48.9±8.8 <0.001
Male sex 237 (38.8) 241 (40.5) 150 (25.0) <0.001
BMI, kg/m2 23.9±2.8 24.3±3.1 24.2±3.2 0.102
Waist circumference, cm 80.2±8.2 81.2±9.2 80.1±9.2 0.055
SBP, mm Hg 117.4±13.9 118.6±14.8 117.2±15.1 0.188
Fasting glucose, mg/dL 89.0 (84.0–96.0) 89.0 (83.0–97.0) 88.0 (83.0–94.0) 0.583
Fasting insulin, μIU/mL 7.4 (6.1–8.9) 7.8 (6.5–9.7) 7.9 (6.4–10.2) 0.001
HOMA-IR, units 1.67 (1.33–2.10) 1.74 (1.40–2.25) 1.74 (1.35–2.35) 0.009
Alcohol consumption, g/day 0.5 (0.0–11.0) 1.1 (0.0–10.2) 0.0 (0.0–5.5) 0.317
Smoking status <0.001
   Never 407 (66.6) 398 (66.9) 455 (75.7)
   Former smoker 118 (19.3) 101 (17.0) 70 (11.7)
   Current smoker 86 (14.1) 96 (16.1) 76 (12.7)
Physical exercise <0.001
   Low 219 (35.8) 243 (40.8) 288 (47.2)
   Moderate 244 (39.9) 238 (40.0) 216 (35.9)
   High 148 (24.2) 114 (19.2) 97 (16.1)
Season <0.001
   May–October 188 (30.8) 118 (19.8) 70 (11.7)
   November–April 423 (69.2) 477 (80.2) 531 (88.4)
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
CMERC, Cardiovascular and Metabolic Disease Etiologic Research Center; 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; SBP, sys-
tolic blood pressure; HOMA-IR, homeostasis model assessment insulin resistance. 
aP values were calculated using Tukey post hoc analysis for continuous variables and chi-square tests for categorical variables.
Table 2. OR of high insulin resistance (HOMA-IR >75 percentile) according to serum 25(OH)D levels
25(OH)D, ng/mL
Model 1a Model 2b Model 3c
OR (95% CI) P for trendd OR (95% CI) P for trendd OR (95% CI) P for trendd
≥14.3 Reference 0.001 Reference 0.001 Reference 0.042
9.7 to <14.3 1.31 (1.00–1.71) 1.37 (1.04–1.80) 1.19 (0.88–1.62)
<9.7 1.57 (1.21–2.04) 1.65 (1.26–2.16) 1.37 (1.01–1.86)
HOMA-IR, homeostasis model assessment insulin resistance; 25(OH)D, 25-hydroxyvitamin D; OR, odds ratio; CI, confidence interval.
aModel 1 was the unadjusted model, bModel 2 adjusted for age and gender, cModel 3 adjusted for age, gender, waist circumference, alcohol 
consumption, smoking status, physical exercise, season, and cohorts, dP for trend indicates the comparison of prevalence of high insulin resis-
tance according to serum 25(OH)D levels.
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Table 3. OR of high insulin resistance (>75 percentile) according to serum 25(OH)D levels stratified by adiposity
25(OH)D, ng/mL High insulin resistance
OR (95% CI)
Model 1a Model 2b Model 3c
General obesity
   Normal
      ≥14.7 47 (12.2) 1.00 (reference) 1.00 (reference) 1.00 (reference)
      9.8 to <14.7 50 (12.9) 1.07 (0.70–1.63) 1.18 (0.76–1.82) 1.20 (0.76–1.88)
      <9.8 63 (16.7) 1.45 (0.96–2.18) 1.53 (1.01–2.32) 1.64 (1.05–2.56)
   Obesity
      ≥13.9 88 (39.8) 1.00 (reference) 1.00 (reference) 1.00 (reference)
      9.6 to <13.9 99 (45.6) 1.27 (0.87–1.85) 1.25 (0.85–1.83) 1.04 (0.68–1.58)
      <9.6 104 (47.7) 1.38 (0.94–2.01) 1.30 (0.88–1.91) 0.97 (0.63–1.48)
Abdominal obesity
   Normal
      ≥14.6 71 (15.0) 1.00 (reference) 1.00 (reference) 1.00 (reference)
      9.8 to <14.6 74 (15.9) 1.06 (0.75–1.52) 1.14 (0.80–1.63) 1.10 (0.76–1.60)
      <9.8 90 (19.5) 1.37 (0.97–1.92) 1.42 (1.00–2.01) 1.33 (0.92–1.93)
   Obesity
      ≥13.8 63 (46.3) 1.00 (reference) 1.00 (reference) 1.00 (reference)
      9.4 to <13.8 75 (54.7) 1.40 (0.87–2.26) 1.38 (0.86–2.24) 1.15 (0.68–1.94)
      <9.4 78 (58.7) 1.64 (1.01–2.66) 1.57 (0.96–2.55) 1.38 (0.81–2.37)
Values are presented as number (%). General obesity was defined as a body mass index of 25 kg/m2 or greater. Abdominal obesity was defined 
as a waist circumference of 90 cm or greater for men and 85 cm or greater for women.
OR, odds ratio; 25(OH)D, 25-hydroxyvitamin D; CI, confidence interval.
aModel 1 was the unadjusted model, bModel 2 adjusted for age and gender, cModel 3 adjusted for age, gender, waist circumference, alcohol 
consumption, smoking status, physical exercise, season, and cohort.
Fig. 1. Adjusted odds ratio of high insulin resistance (>75 percentile) by tertiles (T) of serum 25-hydroxyvitamin D (25(OH)D) 
and adiposity status. (A) General obesity was defined as a body mass index of 25 kg/m2 or greater. (B) Abdominal obesity was 
defined as a waist circumference of 90 cm or greater for men and 85 cm or greater for women. Serum 25(OH)D was categorized 
into T. T1, first tertile; T2, second tertile; T3, third tertile. Model adjusted for age, gender, waist circumference, alcohol con-
sumption, smoking status, physical exercise, season, and cohort. aP<0.05.
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With regard to the Korean population, the Korean Genome 
Epidemiology Study (KoGES)-Kangwha study reported an 
inverse relationship between 25(OH)D concentrations and 
HOMA-IR score, but the association was no longer present 
after adjusting for sex, age, BMI, smoking status, alcohol in-
take, and regular exercise [19]. In contrast, in our study, the 
inverse associations remained after adjustments. However, the 
KoGES-Kangwha study population consisted of 807 rural 
subjects aged 40 to 89 years old, and the authors found that 
25(OH)D concentrations were much higher than those in 
both our study and another study based on the Korea Nation-
al Health and Nutrition Examination Survey (KNHANES IV) 
[13]. Therefore, the differences in results between the KoGES-
Kangwha study and our study might be attributable to differ-
ences in 25(OH)D levels. 
No significant difference of serum 25(OH)D levels based on 
gender was present in this study. Although several studies 
showed serum 25(OH)D levels were higher in males than in 
females [13,20], other studies showed no difference [21] and 
even higher serum 25(OH)D levels in females [22]. Statistical 
adjustment for gender was made as well, with the result that 
younger people showed much lower serum 25(OH)D levels, 
which is consistent with other studies [21,23]. This might be 
the result of their higher indoor activity, lower physical activi-
ty, and lower vitamin D supplement intake.
Most previous studies on vitamin D levels and insulin resis-
tance have focused on the categories of vitamin D deficiency 
(<20 ng/mL), insufficiency (20 to 30 ng/mL), and sufficiency 
(≥30 ng/mL). However, the KNHANES IV reported that the 
prevalence of vitamin D insufficiency was very high, impact-
ing more than 60% of Korean adults [13]. Therefore, addition-
al categories of vitamin D deficiency or insufficiency are 
needed in Korea. We divided subjects based on 25(OH)D con-
centration, using cutoff points of 9.7 and 14.3 ng/mL, both 
lower than the level currently defined as vitamin D deficiency 
(20 ng/mL or 50 nmol/L). To the best of our knowledge, this is 
the first study to have evaluated the association between sub-
divisions of vitamin D deficiency and insulin resistance. Simi-
lar negative associations were observed between vitamin D 
levels and insulin resistance in the vitamin D deficiency sub-
divisions. 
Stratified analyses indicated that the association between 
25(OH)D levels and insulin resistance is not amplified by ab-
dominal obesity, although it is amplified by general obesity. 
This result is not consistent with previous studies, which found 
that abdominal obesity is more strongly associated with insu-
lin resistance than general obesity [24]. Kang et al. [25] re-
ported results that were similar to our study, finding a stron-
ger association between 25(OH)D and insulin resistance 
when stratified by BMI than when stratified by abdominal 
obesity. They insisted that BMI is more reflective of subcuta-
neous fat than waist circumference. Also, previous studies 
have shown that 25(OH)D and obesity may have a synergistic 
effect on insulin resistance risk [14]. However, our study 
showed that the association of 25(OH)D levels with insulin 
resistance was only present in the normal obesity group. Al-
though the storage of 25(OH)D in fat tissues can cause lower 
bioavailable vitamin D, obesity may be a greater effect than 
25(OH)D because obesity is an established risk factor of insu-
lin resistance [26]. So, the relation of 25(OH)D levels with in-
sulin resistance was only significant in the normal obesity 
group, not in the obesity group.
Vitamin D is a multifunctional hormone that is essential to 
many important functions, ranging from calcium and phos-
phorus homeostasis to glucose regulation [1,2]. Although 
previous studies have reported that vitamin D deficiency is as-
sociated with insulin resistance, the mechanism of this associ-
ation has not fully been explained. One potential mechanism 
is that vitamin D may have a direct effect on insulin sensitivity 
through stimulation of insulin receptor expression, together 
with improved insulin-dependent glucose transport [27,28]. 
Another potential mechanism is that vitamin D suppresses 
chronic inflammation, which is associated with obesity and 
insulin resistance [28]. Vitamin D has anti-inflammatory ac-
tions. It dose-dependently suppresses the release of tumor ne-
crosis factor-α and interleukin 6 (IL-6) [29,30], while upregu-
lating the synthesis of the anti-inflammatory cytokine IL-10, 
thus potentially partly counteracting the inflammatory conse-
quences of increased adiposity [28]. 
Strengths of this study were the large sample size and the 
coverage of both rural and urban areas. Thus, our study popu-
lation may be representative of the Korean general popula-
tion. In addition, we included many potential confounders 
(age, gender, BMI, waist circumference, smoking, alcohol 
consumption, physical activity, and season) that could affect 
glucose and vitamin D metabolism, and the final results were 
obtained after adjusting for these confounding factors. How-
ever, this study also had some limitations. First, the blood 
samples were not collected during the same season. So, we ad-
justed for season (May to October, November to April) to ob-
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tain more precise results. Second, data on sunscreen use, sun 
exposure time, diet pattern, and calcium or vitamin D supple-
ment use were not collected. Third, this study cannot establish 
causality between 25(OH)D concentrations and insulin resis-
tance due to the cross-sectional design. Finally, there is a pos-
sibility that unmeasured confounding factors, such as calcium 
and parathyroid hormone levels, might have influenced the 
results.
In conclusion, our study shows that 25(OH)D concentra-
tions in serum have a substantial inverse association with in-
sulin resistance. These results suggest that vitamin D is inde-
pendently associated with insulin resistance in the healthy, 
non-obese Korean population.
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